Origins of MZL genes

Tier 1 MZL genes

42 total

Gene Tier First MZL evidence Other entities
ACTB 1 lohrDiscoveryPrioritizationSomatic2012a?,wienandGenomicAnalysesFlowsorted2019b?
ARID1A 1 Rossi et alrossiCodingGenomeSplenic2012c? 1,2,wienandGenomicAnalysesFlowsorted2019b?,krysiakRecurrentSomaticMutations2017b?
ATM 1 Braggio et al3 4,5
BCL10 1 Spina et alspinaGeneticsNodalMarginal2016b? 6,russler-germainMutationsAssociatedProgression2023b?
BCL7A 1 7,8,krysiakRecurrentSomaticMutations2017b?,reichelFlowSortingExome2015a?
BIRC3 1 Rossi et alrossiAlterationBIRC3Multiple2011a? 4,8,dunsCharacterizationDLBCLPMBL2021b?
BRAF 1 1,tiacciBRAFMutationsHairycell2011a?
BTG1 1 6,burkhardtClinicalRelevanceMolecular2022b?,sarkozyMutationalLandscapeGray2021a?
CARD11 1 Yan et alyanBCRTLRSignaling2012a? 6,911
CCND3 1 Jallades et al12 6,13,richterRecurrentMutationID32012a?
CXCR4 1 9,14,krysiakRecurrentSomaticMutations2017b?
DTX1 1 Rossi et alrossiCodingGenomeSplenic2012c? 1,15,schmitzGeneticsPathogenesisDiffuse2018a?
EP300 1 Rossi et alrossiCodingGenomeSplenic2012c? 9,pasqualucciInactivatingMutationsAcetyltransferase2011a?
EZH2 1 1,mottokIntegrativeGenomicAnalysis2019b?,morinSomaticMutationsAltering2010a?
FAS 1 Spina et alspinaGeneticsNodalMarginal2016b? 16
FAT1 1 Spina et alspinaGeneticsNodalMarginal2016b?
FOXO1 1 6,17,dunsCharacterizationDLBCLPMBL2021b?
H1-4 1
H1-5 1
ID3 1 Spina et alspinaGeneticsNodalMarginal2016b? 17,richterRecurrentMutationID32012a?
KLF2 1 Jallades et al12 13,18
KLHL6 1 Ganapathi et al19 6,9
KMT2D 1 Rossi et alrossiCodingGenomeSplenic2012c? 4,6,7,13
MAP3K14 1 Rossi et alrossiAlterationBIRC3Multiple2011a? ottoGeneticLesionsTRAF32012a?
MPEG1 1 20
MYD88 1 Yan et alyanBCRTLRSignaling2012a? ngoOncogenicallyActiveMYD882011a?
NCOR2 1 Spina et alspinaGeneticsNodalMarginal2016b? 17,sarkozyMutationalLandscapeGray2021a?
NOL9 1 Spina et alspinaGeneticsNodalMarginal2016b? schmitzGeneticsPathogenesisDiffuse2018a?
NOTCH1 1 Rossi et alrossiCodingGenomeSplenic2012c? 1,4,18
NOTCH2 1 Rossi et alrossiCodingGenomeSplenic2012c? 4,9,21
PCLO 1 lohrDiscoveryPrioritizationSomatic2012a?
POU2AF1 1 krysiakRecurrentSomaticMutations2017b?
PTPRD 1 Spina et alspinaGeneticsNodalMarginal2016b?
SIN3A 1 Rossi et alrossiCodingGenomeSplenic2012c? 7
SOCS1 1 6,wenigerMutationsTumorSuppressor2006a?
SPEN 1 Rossi et alrossiCodingGenomeSplenic2012c? sarkozyMutationalLandscapeGray2021a?
STAT6 1 ritzRecurrentMutationsSTAT62009a?,yildizActivatingSTAT6Mutations2015c?
TBL1XR1 1 Rossi et alrossiCodingGenomeSplenic2012c? lohrDiscoveryPrioritizationSomatic2012a?
TNFAIP3 1 Rossi et alrossiAlterationBIRC3Multiple2011a? compagnoMutationsMultipleGenes2009a?,schmitzTNFAIP3A20Tumor2009a?
TNFRSF14 1 Spina et alspinaGeneticsNodalMarginal2016b? 6,cheungAcquiredTNFRSF14Mutations2010a?
TP53 1 Rossi et alrossiCodingGenomeSplenic2012c? 4,6,22,tiacciPervasiveMutationsJAKSTAT2018b?,lohrDiscoveryPrioritizationSomatic2012a?
TRAF3 1 Rossi et alrossiAlterationBIRC3Multiple2011a? 18,ottoGeneticLesionsTRAF32012a?

Tier 2 MZL genes

74 total

Gene Tier First MZL evidence Other entities
ABCA13 2 Spina et alspinaGeneticsNodalMarginal2016b? sarkozyMutationalLandscapeGray2021a?
ACTG1 2 Spina et alspinaGeneticsNodalMarginal2016b? 13,hubschmannMutationalMechanismsShaping2021b?
ADD2 2 Spina et alspinaGeneticsNodalMarginal2016b?
AMN 2 Spina et alspinaGeneticsNodalMarginal2016b?
AMOTL1 2 Parry et al23
AOC2 2 Spina et alspinaGeneticsNodalMarginal2016b?
ARHGAP20 2 Jallades et al12
ARHGEF15 2 Jallades et al12
ARHGEF17 2 Jallades et al12
BCOR 2 Jallades et al12 nadeuGenomicEpigenomicInsights2020b?
C6orf103 2 Spina et alspinaGeneticsNodalMarginal2016b?
CBFA2T3 2 Parry et al23
CD79A 2 Rossi et alrossiCodingGenomeSplenic2012c? burkhardtClinicalRelevanceMolecular2022b?
CD9B 2 Vandenbrand et al24
CDC42BPB 2 Spina et alspinaGeneticsNodalMarginal2016b? hubschmannMutationalMechanismsShaping2021b?
CDKN2A 2 Spina et alspinaGeneticsNodalMarginal2016b? 7,20
CLGN 2 Spina et alspinaGeneticsNodalMarginal2016b?
CNBP 2 Spina et alspinaGeneticsNodalMarginal2016b?
CNKSR2 2 Spina et alspinaGeneticsNodalMarginal2016b?
CREBBP 2 Parry et al23 1,dunsCharacterizationDLBCLPMBL2021b?,pasqualucciInactivatingMutationsAcetyltransferase2011a?
DNAH5 2 Jallades et al12 20
DNAH7 2 Jallades et al12
DNAI1 2 Jallades et al12
DOCK6 2 Jallades et al12
DSP 2
DTNB 2
DTX3L 2 Jallades et al12
EGR1 2 Rossi et alrossiCodingGenomeSplenic2012c? krysiakRecurrentSomaticMutations2017b?,reichelFlowSortingExome2015a?
EGR2 2 Rossi et alrossiCodingGenomeSplenic2012c?
EZH1 2 Jallades et al12
FAT4 2 Parry et al23 20,25
FBXO11 2 Parry et al23 richterRecurrentMutationID32012a?,hubschmannMutationalMechanismsShaping2021b?
GPR98 2 Spina et alspinaGeneticsNodalMarginal2016b?
GPS2 2 Rossi et alrossiCodingGenomeSplenic2012c?
HIST1H1D 2 Jallades et al12 20,krysiakRecurrentSomaticMutations2017b?
HIST1H2AD 2 Jallades et al12
HIST1H2AG 2 Rossi et alrossiCodingGenomeSplenic2012c? 9,20,krysiakRecurrentSomaticMutations2017b?
HIST1H2BK 2 Rossi et alrossiCodingGenomeSplenic2012c? 9
HIST4H4 2 Jallades et al12
HRAS 2 Jallades et al12 5
IKBKB 2 Rossi et alrossiAlterationBIRC3Multiple2011a? 5,wienandGenomicAnalysesFlowsorted2019b?
KAT6A 2 Jallades et al12
KDM6A 2 Jallades et al12
KIF26A 2 Jallades et al12
LRP1B 2 Spina et alspinaGeneticsNodalMarginal2016b?
MCRS1 2 Rossi et alrossiCodingGenomeSplenic2012c?
MGA 2 Jallades et al12 2
MSL2 2 Rossi et alrossiCodingGenomeSplenic2012c?
MYC 2 Jallades et al12 26,pasqualucciHypermutationMultipleProtooncogenes2001a?,dunsCharacterizationDLBCLPMBL2021b?
MYLK 2 Jallades et al12
NCOA6 2 Jallades et al12
NRAS 2 Jallades et al12
PACRG 2 Spina et alspinaGeneticsNodalMarginal2016b?
PARK2 2 Spina et alspinaGeneticsNodalMarginal2016b?
PLA2G4D 2 Parry et al23
PLXNB3 2 Spina et alspinaGeneticsNodalMarginal2016b? 25
RAF1 2 Jallades et al12
RAPGEF2 2
RCOR1 2 Spina et alspinaGeneticsNodalMarginal2016b?
RFTN1 2 8,dunsCharacterizationDLBCLPMBL2021b?
ROCK1 2 Jallades et al12
RPL1L 2 Spina et alspinaGeneticsNodalMarginal2016b?
SAMD5 2 Spina et alspinaGeneticsNodalMarginal2016b?
SCG3 2 Spina et alspinaGeneticsNodalMarginal2016b?
STXBP5 2 Spina et alspinaGeneticsNodalMarginal2016b?
SWAP70 2 Rossi et alrossiCodingGenomeSplenic2012c?
TAF1 2 Spina et alspinaGeneticsNodalMarginal2016b? 20
TBK1 2 Jallades et al12
TCTN2 2 Spina et alspinaGeneticsNodalMarginal2016b?
TNIP2 2 Vandenbrand et al24
TRRAP 2 Rossi et alrossiCodingGenomeSplenic2012c? 23
USH2A 2 Parry et al23
WAC 2 Rossi et alrossiCodingGenomeSplenic2012c? 5
WNK1 2 Jallades et al12 27,hubschmannMutationalMechanismsShaping2021b?

References

1.
Love C, Sun Z, Jima D, Li G, Zhang J, Miles R, Richards KL, Dunphy CH, Choi WWL, Srivastava G, Lugar PL, Rizzieri DA, Lagoo AS, Bernal-Mizrachi L, Mann KP, Flowers CR, Naresh KN, Evens AM, Chadburn A, Gordon LI, Czader MB, Gill JI, Hsi ED, Greenough A, Moffitt AB, McKinney M, Banerjee A, Grubor V, Levy S, Dunson DB, Dave SS. The genetic landscape of mutations in Burkitt lymphoma. Nat Genet. 2012 Dec;44(12):1321–1325. PMCID: PMC3674561
2.
Zhang J, Grubor V, Love CL, Banerjee A, Richards KL, Mieczkowski PA, Dunphy C, Choi W, Au WY, Srivastava G, Lugar PL, Rizzieri DA, Lagoo AS, Bernal-Mizrachi L, Mann KP, Flowers C, Naresh K, Evens A, Gordon LI, Czader M, Gill JI, Hsi ED, Liu Q, Fan A, Walsh K, Jima D, Smith LL, Johnson AJ, Byrd JC, Luftig MA, Ni T, Zhu J, Chadburn A, Levy S, Dunson D, Dave SS. Genetic heterogeneity of diffuse large B-cell lymphoma. Proceedings of the National Academy of Sciences of the United States of America. 2013;110:1398–1403. PMCID: PMC3557051
3.
Braggio E, Dogan A, Keats JJ, Chng WJ, Huang G, Matthews JM, Maurer MJ, Law ME, Bosler DS, Barrett M, Lossos IS, Witzig TE, Fonseca R. Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalities. Mod Pathol. 2012 May;25(5):651–660. PMCID: PMC3341516
4.
Beà S, Valdés-Mas R, Navarro A, Salaverria I, Martín-Garcia D, Jares P, Giné E, Pinyol M, Royo C, Nadeu F, Conde L, Juan M, Clot G, Vizán P, Croce LD, Puente DA, López-Guerra M, Moros A, Roue G, Aymerich M, Villamor N, Colomo L, Martínez A, Valera A, Martín-Subero JI, Amador V, Hernández L, Rozman M, Enjuanes A, Forcada P, Muntañola A, Hartmann EM, Calasanz MJ, Rosenwald A, Ott G, Hernández-Rivas JM, Klapper W, Siebert R, Wiestner A, Wilson WH, Colomer D, López-Guillermo A, López-Otín C, Puente XS, Campo E. Landscape of somatic mutations and clonal evolution in mantle cell lymphoma. PNAS. 2013;110(45):18250–18255.
5.
Reddy A, Zhang J, Davis NS, Moffitt AB, Love CL, Waldrop A, Leppa S, Pasanen A, Meriranta L, Karjalainen-Lindsberg ML, Nørgaard P, Pedersen M, Gang AO, Høgdall E, Heavican TB, Lone W, Iqbal J, Qin Q, Li G, Kim SY, Healy J, Richards KL, Fedoriw Y, Bernal-Mizrachi L, Koff JL, Staton AD, Flowers CR, Paltiel O, Goldschmidt N, Calaminici M, Clear A, Gribben J, Nguyen E, Czader MB, Ondrejka SL, Collie A, Hsi ED, Tse E, Au-Yeung RKH, Kwong YL, Srivastava G, Choi WWL, Evens AM, Pilichowska M, Sengar M, Reddy N, Li S, Chadburn A, Gordon LI, Jaffe ES, Levy S, Rempel R, Tzeng T, Happ LE, Dave T, Rajagopalan D, Datta J, Dunson DB, Dave SS. Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma. Cell. 2017 Oct;171(2):481–494.e15. PMCID: PMC5659841
6.
Morin RD, Mendez-Lago M, Mungall AJ, Goya R, Mungall KL, Corbett RD, Johnson NA, Severson TM, Chiu R, Field M, Jackman S, Krzywinski M, Scott DW, Trinh DL, Tamura-Wells J, Li S, Firme MR, Rogic S, Griffith M, Chan S, Yakovenko O, Meyer IM, Zhao EY, Smailus D, Moksa M, Chittaranjan S, Rimsza L, Brooks-Wilson A, Spinelli JJ, Ben-Neriah S, Meissner B, Woolcock B, Boyle M, McDonald H, Tam A, Zhao Y, Delaney A, Zeng T, Tse K, Butterfield Y, Birol I, Holt R, Schein J, Horsman DE, Moore R, Jones SJM, Connors JM, Hirst M, Gascoyne RD, Marra MA. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature. 2011 Jul 27;476(7360):298–303. PMCID: PMC3210554
7.
Grande BM, Gerhard DS, Jiang A, Griner NB, Abramson JS, Alexander TB, Allen H, Ayers LW, Bethony JM, Bhatia K, Bowen J, Casper C, Choi JK, Culibrk L, Davidsen TM, Dyer MA, Gastier-Foster JM, Gesuwan P, Greiner TC, Gross TG, Hanf B, Harris NL, He Y, Irvin JD, Jaffe ES, Jones SJM, Kerchan P, Knoetze N, Leal FE, Lichtenberg TM, Ma Y, Martin JP, Martin MR, Mbulaiteye SM, Mullighan CG, Mungall AJ, Namirembe C, Novik K, Noy A, Ogwang MD, Omoding A, Orem J, Reynolds SJ, Rushton CK, Sandlund JT, Schmitz R, Taylor C, Wilson WH, Wright GW, Zhao EY, Marra MA, Morin RD, Staudt LM. Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma. Blood. 2019;133(12):1313–1324. PMCID: PMC6428665
8.
Arthur SE, Jiang A, Grande BM, Alcaide M, Cojocaru R, Rushton CK, Mottok A, Hilton LK, Lat PK, Zhao EY, Culibrk L, Ennishi D, Jessa S, Chong L, Thomas N, Pararajalingam P, Meissner B, Boyle M, Davidson J, Bushell KR, Lai D, Farinha P, Slack GW, Morin GB, Shah S, Sen D, Jones SJM, Mungall AJ, Gascoyne RD, Audas TE, Unrau P, Marra MA, Connors JM, Steidl C, Scott DW, Morin RD. Genome-wide discovery of somatic regulatory variants in diffuse large B-cell lymphoma. Nat Commun. 2018 Oct 1;9(1):4001. PMCID: PMC6167379
9.
Panea R, Love C, Shingleton JR, Reddy A, Bailey J, Moormann A, Otieno J, Ong’echa J, Oduor C, Schroêder K, Masalu N, Chao N, Agajanian M, Major M, Fedoriw Y, Richards K, Rymkiewicz G, Miles R, Alobeid B, Bhagat G, Flowers C, Ondrejka S, Hsi E, Choi W, Au-Yeung R, Hartmann W, Lenz G, Meyerson H, Lin YY, Zhuang Y, Luftig M, Waldrop A, Dave T, Thakkar D, Sahay H, Li G, Palus B, Seshadri V, Kim S, Gascoyne R, Levy S, Mukhopadhyay M, Dunson D, Dave S. The whole genome landscape of Burkitt lymphoma subtypes. Blood. 2019;
10.
Lenz G, Davis RE, Ngo VN, Lam L, George TC, Wright GW, Dave SS, Zhao H, Xu W, Rosenwald A, Ott G, Müller-Hermelink HK, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Fisher RI, Chan WC, Staudt LM. Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science. 2008 Mar;319(5870):1676–1679.
11.
Wu C, de Miranda NF, Chen L, Wasik AM, Mansouri L, Jurczak W, Galazka K, Dlugosz-Danecka M, Machaczka M, Zhang H, Peng R, Morin RD, Rosenquist R, Sander B, Pan-Hammarström Q. Genetic heterogeneity in primary and relapsed mantle cell lymphomas: Impact of recurrent CARD11 mutations. Oncotarget. 2016 Jun 21;7(25):38180–38190. PMCID: PMC5122381
12.
Jallades L, Baseggio L, Sujobert P, Huet S, Chabane K, Callet-Bauchu E, Verney A, Hayette S, Desvignes JP, Salgado D, Levy N, Béroud C, Felman P, Berger F, Magaud JP, Genestier L, Salles G, Traverse-Glehen A. Exome sequencing identifies recurrent BCOR alterations and the absence of KLF2, TNFAIP3 and MYD88 mutations in splenic diffuse red pulp small B-cell lymphoma. Haematologica. 2017 Oct;102(10):1758–1766. PMCID: PMC5622860
13.
Desch AK, Hartung K, Botzen A, Brobeil A, Rummel M, Kurch L, Georgi T, Jox T, Bielack S, Burdach S, Classen CF, Claviez A, Debatin KM, Ebinger M, Eggert A, Faber J, Flotho C, Frühwald M, Graf N, Jorch N, Kontny U, Kramm C, Kulozik A, Kühr J, Sykora KW, Metzler M, Müller HL, Nathrath M, Nüßlein T, Paulussen M, Pekrun A, Reinhardt D, Reinhard H, Rössig C, Sauerbrey A, Schlegel PG, Schneider DT, Scheurlen W, Schweigerer L, Simon T, Suttorp M, Vorwerk P, Schmitz R, Kluge R, Mauz-Körholz C, Körholz D, Gattenlöhner S, Bräuninger A. Genotyping circulating tumor DNA of pediatric Hodgkin lymphoma. Leukemia. 2020 Jan;34(1):151–166.
14.
Khodabakhshi AH, Morin RD, Fejes AP, Mungall AJ, Mungall KL, Bolger-Munro M, Johnson NA, Connors JM, Gascoyne RD, Marra MA, Birol I, Jones SJM. Recurrent targets of aberrant somatic hypermutation in lymphoma. Oncotarget. 2012;3(11):1308–1319. PMCID: PMC3717795
15.
Gomez F, Fisk B, McMichael JF, Mosior M, Foltz JA, Skidmore ZL, Duncavage EJ, Miller CA, Abel H, Li YS, Russler-Germain DA, Krysiak K, Watkins MP, Ramirez CA, Schmidt A, Martins Rodrigues F, Trani L, Khanna A, Wagner JA, Fulton RS, Fronick CC, O’Laughlin MD, Schappe T, Cashen AF, Mehta-Shah N, Kahl BS, Walker J, Bartlett NL, Griffith M, Fehniger TA, Griffith OL. Ultra-Deep Sequencing Reveals the Mutational Landscape of Classical Hodgkin Lymphoma. Cancer Res Commun. 2023 Nov 15;3(11):2312–2330. PMCID: PMC10648575
16.
Scholl V, Stefanoff CG, Hassan R, Spector N, Renault IZ. Mutations within the 5’ region of FAS/CD95 gene in nodal diffuse large B-cell lymphoma. Leuk Lymphoma. 2007 May;48(5):957–963.
17.
Schmitz R, Young RM, Ceribelli M, Jhavar S, Xiao W, Zhang M, Wright G, Shaffer AL, Hodson DJ, Buras E, Liu X, Powell J, Yang Y, Xu W, Zhao H, Kohlhammer H, Rosenwald A, Kluin P, Müller-Hermelink HK, Ott G, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Ogwang MD, Reynolds SJ, Fisher RI, Braziel RM, Tubbs RR, Cook JR, Weisenburger DD, Chan WC, Pittaluga S, Wilson W, Waldmann TA, Rowe M, Mbulaiteye SM, Rickinson AB, Staudt LM. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature. 2012 Oct 4;490(7418):116–120. PMCID: PMC3609867
18.
Pasqualucci L, Trifonov V, Fabbri G, Ma J, Rossi D, Chiarenza A, Wells VA, Grunn A, Messina M, Elliot O, Chan J, Bhagat G, Chadburn A, Gaidano G, Mullighan CG, Rabadan R, Dalla-Favera R. Analysis of the coding genome of diffuse large B-cell lymphoma. Nat Genet. 2011 Jul 31;43(9):830–837. PMCID: PMC3297422
19.
Ganapathi KA, Jobanputra V, Iwamoto F, Jain P, Chen J, Cascione L, Nahum O, Levy B, Xie Y, Khattar P, Hoehn D, Bertoni F, Murty VV, Pittaluga S, Jaffe ES, Alobeid B, Mansukhani MM, Bhagat G. The genetic landscape of dural marginal zone lymphomas. Oncotarget. Impact Journals; 2016 May 27;7(28):43052–43061.
20.
Morin RD, Mungall K, Pleasance E, Mungall AJ, Goya R, Huff RD, Scott DW, Ding J, Roth A, Chiu R, Corbett RD, Chan FC, Mendez-Lago M, Trinh DL, Bolger-Munro M, Taylor G, Hadj Khodabakhshi A, Ben-Neriah S, Pon J, Meissner B, Woolcock B, Farnoud N, Rogic S, Lim EL, Johnson NA, Shah S, Jones S, Steidl C, Holt R, Birol I, Moore R, Connors JM, Gascoyne RD, Marra MA. Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing. Blood. 2013 Aug 15;122(7):1256–1265. PMCID: PMC3744992
21.
Trøen G, Wlodarska I, Warsame A, Hernández Llodrà S, De Wolf-Peeters C, Delabie J. NOTCH2 mutations in marginal zone lymphoma. Haematologica. 2008 Jul;93(7):1107–1109.
22.
Wilda M, Bruch J, Harder L, Rawer D, Reiter A, Borkhardt A, Woessmann W. Inactivation of the ARF-MDM-2-p53 pathway in sporadic Burkitt’s lymphoma in children. Leukemia. 2004 Mar;18(3):584–588.
23.
Parry M, Rose-Zerilli MJJ, Gibson J, Ennis S, Walewska R, Forster J, Parker H, Davis Z, Gardiner A, Collins A, Oscier DG, Strefford JC. Whole exome sequencing identifies novel recurrently mutated genes in patients with splenic marginal zone lymphoma. PLoS One. 2013;8(12):e83244. PMCID: PMC3862727
24.
van den Brand M, Rijntjes J, Hebeda KM, Menting L, Bregitha CV, Stevens WBC, van der Velden WJFM, Tops BBJ, van Krieken JHJM, Groenen PJTA. Recurrent mutations in genes involved in nuclear factor-κB signalling in nodal marginal zone lymphoma-diagnostic and therapeutic implications. Histopathology. 2017 Jan;70(2):174–184.
25.
Zhang J, Jima D, Moffitt AB, Liu Q, Czader M, Hsi ED, Fedoriw Y, Dunphy CH, Richards KL, Gill JI, Sun Z, Love C, Scotland P, Lock E, Levy S, Hsu DS, Dunson D, Dave SS. The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells. Blood. 2014 May 8;123(19):2988–2996.
26.
Johnston JM, Carroll WL. C-myc hypermutation in Burkitt’s lymphoma. Leuk Lymphoma. 1992 Dec;8(6):431–439.
27.
Thomas N, Dreval K, Gerhard DS, Hilton LK, Abramson JS, Ambinder RF, Barta S, Bartlett NL, Bethony J, Bhatia K, Bowen J, Bryan AC, Cesarman E, Casper C, Chadburn A, Cruz M, Dittmer DP, Dyer MA, Farinha P, Gastier-Foster JM, Gerrie AS, Grande BM, Greiner T, Griner NB, Gross TG, Harris NL, Irvin JD, Jaffe ES, Henry D, Huppi R, Leal FE, Lee MS, Martin JP, Martin MR, Mbulaiteye SM, Mitsuyasu R, Morris V, Mullighan CG, Mungall AJ, Mungall K, Mutyaba I, Nokta M, Namirembe C, Noy A, Ogwang MD, Omoding A, Orem J, Ott G, Petrello H, Pittaluga S, Phelan JD, Ramos JC, Ratner L, Reynolds SJ, Rubinstein PG, Sissolak G, Slack G, Soudi S, Swerdlow SH, Traverse-Glehen A, Wilson WH, Wong J, Yarchoan R, ZenKlusen JC, Marra MA, Staudt LM, Scott DW, Morin RD. Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma. Blood. 2023 Feb 23;141(8):904–916. PMCID: PMC10023728